Lookabetter

EKR Therapeutics, Inc., a specialty pharmaceutical company focused on providing novel products for the acute-care hospital setting, announced that it received approval from the U.S. Food and Drug Administration for Cardene® I.V. (nicardipine hydrochloride) premixed injection, a patented, ready-to-use (RTU), single use intravenous bag for the administration of this calcium channel blocker. The 200 ml RTU bags contain 20 mg of the anti-hypertensive agent nicardipine hydrochloride Read more…

Two new studies suggest that male circumcision may assist in the prevention of human papillomavirus (HPV) infection, particularly infection with the high-risk subtypes associated with cervical, penile, and other cancers.
Both studies are published in the January 1 issue of The Journal of Infectious Diseases , now available online.
High-risk subtypes of HPV have been estimated to be present in 99.7 percent of cervical cancers worldwide. Read more…

As the Conservative party today predicts that we will see a staggering 26% increase in the number of people experiencing mental health problems by 2010 as a direct result of Britain’s economic crisis, leading mental health charity Mind says that more investment is needed in services to help cope with Read more…